IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q4 2021 Holdings

Filed 2022-02-14 | 11 holdings | $211.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$154.3M643,00073.1%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$55.9M4,039,60026.5%
Alkermes PLC(ALKS)SHSG01767105$326.6K14,040,0000.2%
Gilead Sciences Inc(GILD)COM375558103$209.8K2,889,3000.1%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$191.1K16,390,0000.1%
Innoviva Inc(INVA)COM45781M101$114.1K6,614,0000.1%
Amarin Corp PLCSPONS ADR NEW023111206$64.9K19,250,0000.0%
Mersana Therapeutics IncCOM59045L106$26.7K4,299,2970.0%
VOR Biopharma IncCOM929033108$8.2K707,0100.0%
Pear Therapeutics IncCLASS A COM704723105$3.1K500,3560.0%
Regulus Therapeutics IncCOM NEW75915K200$5831,851,8510.0%